Science Matters: Setting The Stage For Using Wearables In Oncology Drug Development

 
• By Mark Ratner

Digital biomarkers using data collected with wearable devices are making their way into clinical trials, largely in cardiovascular, respiratory and rare disease settings around physical activity metrics.

Lightbulb
• Source: Shutterstock

[Editor's Note: This article originally appeared on 16 October in In Vivo, Medtech Insight's sister publication.] 

Applications in oncology are moving at a more deliberate pace owing to the distinctive nature of cancer patients’ needs

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from Medtech Insight